Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay

被引:20
|
作者
Barnes, Edward L. [1 ]
Kochar, Bharati [1 ]
Long, Millie D. [1 ,2 ]
Martin, Christopher F. [1 ,2 ]
Kappelman, Michael D. [2 ,3 ]
机构
[1] Univ North Carolina Chapel Hill, Div Gastroenterol & Hepatol, 130 Mason Farm Rd,Bioinformat Bldg,CB 7080, Chapel Hill, NC 27599 USA
[2] Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA
[3] Univ North Carolina Chapel Hill, Div Pediat Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
race; length of stay; pediatric inflammatory bowel disease; SERIOUS BACTERIAL-INFECTIONS; FACTOR-ALPHA ANTAGONISTS; NON-HISPANIC WHITES; UNITED-STATES; ULCERATIVE-COLITIS; CROHNS-DISEASE; AFRICAN-AMERICANS; RETROSPECTIVE COHORT; RACIAL DISPARITIES; COLECTOMY RATES;
D O I
10.1097/MIB.0000000000001267
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Genetic and other biological factors may lead to differences in disease behavior among children with inflammatory bowel disease of different races, which may be further modified by disparities in care delivery. Using the Kids' Inpatient Database, we aimed to evaluate differences in the management of pediatric patients with inflammatory bowel disease by race, focusing on length of stay (LOS). Methods: We performed a cross-sectional analysis using 2000 to 2012 data from the Kids' Inpatient Database, a nationally representative database. We identified pediatric patients (<= 18 years of age) with discharge diagnoses of Crohn's disease (CD) or ulcerative colitis (UC). We used multivariable logistic regression to evaluate the relationship between race and LOS, controlling for age, payer status need for surgery, and year of admission. Results: We identified 27,295 hospitalizations for children with inflammatory bowel disease (62% CD and 38% UC), Compared with white patients with CD, black (adjusted odds ratio 1.37; 95% confidence interval, 1.22-1.53; P < 0.001) and Hispanic patients (adjusted odds ratio: 1.37; 95% confidence interval: 1.19-1.59; P < 0.001) with CD demonstrated increased odds of a LOS greater than the 75th percentile. When compared with white patients with UC, Hispanic patients also demonstrated increased odds of a LOS greater than the 75th percentile (adjusted odds ratio: 1.20; 95% confidence interval, 1.02-1.42, P = 0.015). Conclusions: After controlling for age, year of admission, and clinical phenotypes, black and Hispanic patients with CD and Hispanic patients with UC had longer LOS than white patients. These may be due to differences in provider/hospital characteristics, socioeconomic differences, and/or differences in genetics and other biological factors.
引用
收藏
页码:2189 / 2196
页数:8
相关论文
共 50 条
  • [21] Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?
    Gandhi, Sumeet
    Narula, Neeraj
    Marshall, John K.
    Farkouh, Michael
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (10) : 956 - 962
  • [22] Inflammatory bowel disease in young patients: challenges faced by black and minority ethnic communities in the UK
    Alexakis, Christopher
    Nash, Avril
    Lloyd, Michele
    Brooks, Fiona
    Lindsay, James O.
    Poullis, Andrew
    HEALTH & SOCIAL CARE IN THE COMMUNITY, 2015, 23 (06) : 665 - 672
  • [23] Serum Endocan Levels are Increased in Patients with Inflammatory Bowel Disease
    Voiosu, Theodor
    Balanescu, Paul
    Bengus, Andreea
    Voiosu, Andrei
    Baicus, Cristian Rasvan
    Barbu, Maria
    Ladaru, Anca
    Nitipir, Cornelia
    Mateescu, Bogdan
    Diculescu, Mircea
    Voiosu, Radu
    CLINICAL LABORATORY, 2014, 60 (03) : 505 - 510
  • [24] Epicardial Adipose Tissue Is Increased in Patients With Inflammatory Bowel Disease
    Uysal, Fatma
    Akbal, Erdem
    Akbal, Ayla
    Cevizci, Sibel
    Arik, Kasim
    Gazi, Emine
    JOURNAL OF ULTRASOUND IN MEDICINE, 2016, 35 (09) : 1859 - 1864
  • [25] Clinical characteristics of Iranian pediatric patients with inflammatory bowel disease
    Fallahi, Gholam-Hossein
    Moazzami, Kasra
    Tabatabaeiyan, Maryam
    Zamani, Mohammad Mehdi
    Asgar-Shirazi, Masoumeh
    Najafi, Mehri
    Motamed, Farzaneh
    Farahmand, Fatemeh
    Khodad, Ahmad
    Khatami, Gholam-Reza
    Rezaei, Nima
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2009, 72 (02) : 230 - 234
  • [26] New serological markers in pediatric patients with inflammatory bowel disease
    Kovacs, Marta
    Mueller, Katalin Eszter
    Papp, Maria
    Lakatos, Peter Laszlo
    Csoendes, Mihaly
    Veres, Gabor
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (17) : 4873 - 4882
  • [27] Infusion Reactions to Infliximab in Pediatric Patients with Inflammatory Bowel Disease
    Dharmaraj, Rajmohan
    Lemon, Tess Pei
    Elmaoued, Rasha
    Castillo, Ricardo Orlando
    Alkhouri, Razan
    CHILDREN-BASEL, 2024, 11 (11):
  • [28] New serological markers in pediatric patients with inflammatory bowel disease
    Márta Kovács
    Katalin Eszter Müller
    Mária Papp
    Péter László Lakatos
    Mihály Cs?ndes
    Gábor Veres
    World Journal of Gastroenterology, 2014, (17) : 4873 - 4882
  • [29] Imaging of Pediatric Patients With Inflammatory Bowel Disease
    Duigenan, Shauna
    Gee, Michael S.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (04) : 907 - 915
  • [30] Association of Inflammatory Bowel Disease and Urolithiasis in Hospitalized Pediatric Patients
    Stark, Christopher M.
    Gorman, Gregory H.
    Nylund, Cade M.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : 1777 - 1782